Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS-102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The ...

Gastric adenocarcinoma carries a poor prognosis, in part due to the late stage of diagnosis. Risk factors include Helicobacter pylori infection, family history of gastric cancer—in particular, ...

1 Génétique Oncologique EPHE, INSERM U753, Institut de cancérologie Gustave Roussy Villejuif; and Faculté de Médecine Paris-Sud, Le Kremlin-Bicêtre, France 2 Service de Génétique, Institut de ...

Therapeutic target identification and corresponding drug development is a demanding task for the treatment of lung adenocarcinoma, especially the most malignant proximal-proliferative subtype without ...

However, the yellow-orange appearance is absent in up to 53% of PICCs detected on OCT. (7) Since PICCs are associated with VFDs similar to those of glaucoma in up to 73.3% of cases, (8) this can lead ...

He had been diagnosed with locally invasive adenocarcinoma of the prostate ... Soon after the resection started, bilateral papillary tumors arising from the stroma of both prostatic lobes were ...

An accurate computational detection model may help the precise diagnose of thyroid papillary cancer (TPC). A standard protocol captures at least the transverse and longitudinal ultrasonograms of the ...

European and non-European experts performed systematic reviews and used GRADE methodology to answer relevant clinical questions on nine topics (biomarkers, radiology, endoscopy, intraductal papillary ...

Pancreatic ductal adenocarcinoma (PDAC) remains one of the malignancies with the highest mortality rates, and outcomes are particularly poor in cases of liver metastasis. Early or recurrent metastatic ...

A total thyroidectomy was performed and histopathological analysis of the nodule revealed follicular variant of papillary thyroid carcinoma. Currently, the patient has been receiving palliative ...

1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. 2Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.